Literature DB >> 26832167

Prostate cancer: Immunotherapy with PPV effective.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26832167     DOI： 10.1038/nrurol.2016.27

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer.

Authors:  Kazuhiro Yoshimura; Takafumi Minami; Masahiro Nozawa; Takahiro Kimura; Shin Egawa; Hiroyuki Fujimoto; Akira Yamada; Kyogo Itoh; Hirotsugu Uemura
Journal:  Eur Urol       Date:  2016-01-15       Impact factor: 20.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.